Search
for
Sort by
Research 211–240 of 1000+
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Fibromodulin reduces scar formation in adult cutaneous wounds by eliciting a fetal-like phenotype
- Interventions for female pattern hair loss
- Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1
- Sexuality in premature ovarian insufficiency
- Metabolic Syndrome Prevalence in Psoriasis
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Contemporary medical therapy for polycystic ovary syndrome
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Nonclassic congenital adrenal hyperplasia
- Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use
- Bone density is normal in male rats treated with finasteride.
- Parkinson's disease and skin
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- In the eye of the beholder
- New approaches to the treatment of osteoporosis
- Central Centrifugal Cicatricial Alopecia: New Insights and a Call for Action
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- New drugs under investigation for the treatment of alopecias
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature
- Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone
- Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes
- Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims